Ellansé M

Ellansé M is a sterile, single use, latex-free, non-pyrogenic, bioresorbable and non-permanent injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial ageing signs or conditions. It is the range option for more extensive volume augmentation, offering 24 months of longevity against 18 months for Ellansé S, thanks to the longer PCL chain length of its microspheres. Synthetic Poly-e-caprolactone (PCL) microspheres make up 30% of the implant, in a 70% carrier gel of phosphate buffered saline, glycerin and carboxymethylcellulose (CMC): the gel fills immediately and is resorbed 2 to 3 months after injection, after which the microspheres progressively stimulate the patient's own collagen, predominantly type I. It is supplied as 2 x 1 mL ready-to-use syringes with four 27G needles and is a Class III medical device CE marked since 2009 under Medical Device Directive 93/42/EEC.

• Immediate correction of facial volume loss from the carboxymethylcellulose carrier gel, which is resorbed 2 to 3 months after injection
• Progressive stimulation of the patient's own collagen, predominantly type I, by the polycaprolactone microspheres
• 30% PCL microspheres to 70% CMC-based carrier gel, with a microsphere diameter of 25 to 50 microns
• 24 months of longevity, against 18 months for Ellanse S, the two being distinguished only by the initial polymer chain length of the PCL
• 100% of patients treated with Ellanse M had improved, much improved or very much improved results at 24 months
• The option for more extensive volume augmentation within the Ellanse family, where Ellanse S is the option for minimal augmentation
• Treats upper, mid and lower face: forehead, temples, brow, nose, cheeks, nasolabial folds, oral commissures, marionette lines, chin and jawline
• Sterile, single use, latex-free, non-pyrogenic, bioresorbable and non-permanent
• Supplied as 2 x 1 mL ready-to-use syringes with four 27G needles
• Class III medical device, CE marked since 2009

適応と専門的な使用

主な適応

• Subdermal implantation in the face for the lasting correction of wrinkles and facial ageing signs or conditions
• Correction of age-related volume loss due to increased skin laxity, fat loss and diminished support from underlying muscle and bone
• More extensive volume augmentation, which is the position of Ellanse M within the range

専門的な使用

This product is supplied for administration by qualified medical practitioners only, within the scope of their professional registration and local regulations for injectable medical devices. It is a stand-alone device and is not required to be used in combination with any other device to meet its intended purpose. Injection technique, plane and volume are determined by the treating practitioner on a per-patient basis, with the approach depending on the facial region, the depth of implantation and the desired degree of volume correction. Selection between Ellanse S and Ellanse M is a decision about the degree of correction and the longevity required, and the two must not be treated as interchangeable. Each unit is sterile and for single use only.

施術部位

• Upper face: forehead, temples, brow area
• Mid face: nose reshaping, cheek augmentation, nasolabial folds
• Lower face: oral commissures, marionette lines, chin definition, jawline
• Injected subdermally, into the subcutaneous fat or hypodermis, with modalities recommended per facial region and per area

対象となる患者

Intended for adult patients over 18 who are not pregnant or breast-feeding and who are deemed appropriate for treatment by the physician. Because polycaprolactone is a bioresorbable implant rather than a hyaluronic acid gel, patient selection and expectation setting carry additional weight and are determined by the practitioner at consultation.

作用の仕組み： Ellansé M ​

Allparaで注文する理由

Allparaは、正規品で検証済みの ELLANSÉ 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。

よくある質問